MetLife guidance steady into Q2, shares track US insurance peers

MetLife heads toward its early August earnings date with stable guidance and a consensus picture that lines up with other large US insurers, while the NYSE-listed shares reflect the sector’s cautious tone.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-25, 14:31.

MetLife Inc. (US59156R1086) enters the second half of 2026 with its earnings guidance unchanged and the next quarterly update scheduled for early August on the NYSE. Analyst consensus for the US life insurer sets a clear picture for revenue and earnings expectations according to MarketScreener.

What consensus shows for MetLife

Sell-side coverage on MetLife centers on its role alongside peers such as Prudential Financial and Manulife in the global life and health insurance space. On MarketScreener, the stock carries a majority of Buy and Hold ratings, with only a small minority recommending selling the shares.

Consensus data for MetLife’s 2026 financial year point to low-single-digit premium growth and a stable combined ratio, reflecting cautious assumptions on claims and investment returns. The aggregated analyst estimates also imply only moderate earnings-per-share expansion, consistent with the broader US insurance cohort according to a recent sector note from UBS.

Upcoming earnings and key dates

MetLife’s investor relations calendar highlights the next earnings release for the second quarter of 2026 in early August, followed by a standard conference call with management. The company typically reports after the US market close, with the NYSE listing providing liquidity for both domestic and international investors.

Dividend timing remains an additional focal point for analysts, with MetLife maintaining a regular quarterly payout schedule in line with other large US insurers, as outlined in the firm’s latest annual report. Ratings agencies continue to assess MetLife’s capital position as robust, a factor that supports ongoing distributions according to a recent Fitch commentary.

How MetLife makes its money

MetLife generates most of its revenue from life insurance, annuities and employee benefits, supplemented by asset management and retirement products. In the US, it is a major provider of group life and dental coverage, while its international segment focuses on protection and savings solutions in markets such as Japan and Latin America.

Where the stock trades today

The MetLife shares (US59156R1086) trade on the NYSE at around 70 US dollars as of 2026-06-25, 14:30 Eastern Time, reflecting a market capitalization in the tens of billions of dollars.

Key data on the MetLife shares

• Company: MetLife Inc.
• ISIN: US59156R1086
• WKN: 934623
• Ticker: MET
• Trading venue: NYSE
• Price (as of 2026-06-25, 14:30): 70.00 USD
• Market cap: 50.00 billion USD (as of 2026-06-25)
• Sector / industry: Financials / Life & Health Insurance
• Index membership: S&P 500
• Next earnings date: 2026-08-01

Disclaimer: This article is for information purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or any other form of financial guidance.